Balldin G, Ohlsson K, Olsson A S
Hoppe Seylers Z Physiol Chem. 1978 Jun;359(6):691-7. doi: 10.1515/bchm.1978.359.1.691.
The distribution of trypsin between the protease inhibitors of human serum with and without Trasylol was studied in vitro. 1) Trypsin was preferentially bound by alpha2-macroglobulin on addition of small amounts of the enzyme to normal serum in both the presence and absence of Trasylol in a molar concentration equal to that of alpha2-macroglobulin. 2) On saturation of alpha2-macroglobulin, a considerable amount of trypsin was bound by Trasylol even when most of the serum alpha1-antitrypsin was in a free form. 3) In reaction mixtures containing small amounts of trypsin, Trasylol was identified in a free form as well as in complex with trypsin-alpha2-macroglobulin complex and to a limited extent with trypsin. 4) With larger amounts of trypsin, sufficient to saturate alpha2-macroglobulin, increasing amounts of Trasylol were bound to trypsin. The relative amount of Trasylol bound to trypsin-alpha2-macroglobulin complexes was now smaller. This was explained by a higher affinity (or binding rate) of Trasylol for trypsin than for trypsin-alpha2-macroglobulin complexes. 5) Trypsin-Trasylol complexes showed no signs of dissociation after 5 h incubation at 37 degrees C in serum.
在体外研究了有无抑肽酶时胰蛋白酶在人血清蛋白酶抑制剂之间的分布情况。1)在向正常血清中添加少量胰蛋白酶时,无论有无摩尔浓度与α2-巨球蛋白相等的抑肽酶,胰蛋白酶都优先与α2-巨球蛋白结合。2)当α2-巨球蛋白饱和时,即使大部分血清α1-抗胰蛋白酶呈游离形式,仍有相当数量的胰蛋白酶与抑肽酶结合。3)在含有少量胰蛋白酶的反应混合物中,抑肽酶以游离形式以及与胰蛋白酶-α2-巨球蛋白复合物结合的形式存在,且与胰蛋白酶的结合程度有限。4)当胰蛋白酶量足够大以致α2-巨球蛋白饱和时,与胰蛋白酶结合的抑肽酶量增加。此时与胰蛋白酶-α2-巨球蛋白复合物结合的抑肽酶相对量减少。这是因为抑肽酶对胰蛋白酶的亲和力(或结合速率)高于对胰蛋白酶-α2-巨球蛋白复合物的亲和力。5)在血清中于37℃孵育5小时后,胰蛋白酶-抑肽酶复合物未显示解离迹象。